Autonome Regulationsstörungen beim idiopathischen Parkinson-Syndrom

Zusammenfassung

Bei vielen Patienten mit einen idiopathischen Parkinson-Syndrom treten im Krankheitsverlauf vegetative Symptome auf. Sie sind gegenüber autonomer Regulationsstörungen bei der Multisystematrophie meist weniger stark ausgeprägt und werden häufig erst im längeren Verlauf symptomatisch. Am ausgeprägtesten zeigen sich die Symptome im kardiovaskulären, gastrointestinalen und urogenitalen Bereich. Durch adäquate Diagnostik und Therapie lässt sich ein erheblicher Nutzen für die Patienten erzielen. Ein interdisziplinäres Vorgehen erweist sich in vielen Fällen als vorteilhaft.

Autonomic Dysregulation in Patients with Idopathic Parkinson's Disease

Most patients with Parkinson's disease experience autonomic dysfunction at some point of their disease course. In contrast to autonomic dysregulation in multisystem atrophy, they are less severe and they frequently cause troublesome symptoms only in advanced stages of the disease. Cardiovascular, gastrointestinal and urogenital autonomic dysfunction is predominant. Appropriate diagnosis and treatment can greatly benefit the patient. An interdisciplinary approach is preferable in most cases.

Literatur

• 1 Jost W H. Autonome Regulationsstörungen beim Parkinson-Syndrom. Aachen; Shaker-Verlag 1999
• 2 Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. (in Druck)
• 3 Mesec A, Sega S, Kiauta T. The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic response.  Clin Auton Res. 1993;  3 339-344
• 4 Micieli G, Martignoni E, Cavallini A. et al . Postprandial and orthostatic hypotension in Parkinson's disease.  Neurology. 1987;  37 386-393
• 5 Turkka J T, Tolonen U, Myllylä V V. Cardiovascular reflexes in Parkinson's disease.  Eur Neurol. 1987;  26 104-112
• 6 Wakabayashi K, Takahashi H, Ohama E. et al . Lewy bodies in the visceral autonomic nervous system in Parkinson's disease.  Adv Neurology. 1993;  60 609-612
• 7 Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease.  Eur Neurol. 1997;  38, Suppl 2 2-7
• 8 Senard J M, Valet P, Durrieu G. et al . Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension.  Eur J Clin Invest. 1990;  20 613-619
• 9 Chaudhuri K R, Ellis C, Love-Jones S. et al . Postprandial hypotension and parkinsonian state in Parkinson's disease.  Mov Disord. 1997;  12 877-884
• 10 Braune S, Lücking C H. Orthostatische Hypotonie: Pathophysiologie, Diagnostik, Therapie.  Dtsch Ärztebl. 1997;  94 A 3413-A 3418
• 11 Fischer M, Gemende I, Marsch W C, Fischer P A. Skin function and skin disorders in Parkinson's disease.  J Neural Transm. 2001;  108 205-213
• 12 Oppenheim H. Kleine Beiträge zur Neuropathologie.  J Psychol Neurol. 1902;  1 129-146
• 13 Taly A B, Muthane U B. Involvement of peripheral nervous system in juvenile Parkinons's disease.  Acta Neurol Scand. 1992;  85 272-275
• 14 Aminoff M J, Wilcox C S. Assessment of autonomic function in patients with a Parkinsonian syndrome.  Br Med J. 1971;  4 80-84
• 15 Martignoni E, Pacchetti C, Godi L. et al . Autonomic disorders in Parkinson's disease.  J Neural Transm. 1995;  45, Suppl 11-19
• 16 Eadie M J, Tyrer J H. Alimentary disorder in parkinsonism.  Australas Ann Med. 1965;  14 13-22
• 17 Schwab R S, England A C. Parkinson's disease.  J Chron Dis. 1958;  8 488-509
• 18 Jost W H. Treatment of drooling in Parkinson's disease with botulinum toxin.  Mov Disord. 1999;  14 1057
• 19 Parkinson J. An essay on the shaking palsy. London; Sherwood, Neely, and Jones 1817
• 20 Bushmann M, Dobmeyer S M, Leeker L. et al . Swallowing abnormalities and their response to treatment in Parkinson's disease.  Neurology. 1989;  39 1309-1314
• 21 Edwards L, Quigley E MM, Hofman R. et al . Gastrointestinal symptoms in Parkinson's Disease: 18-month follow-up study.  Mov Disord. 1993;  8 83-86
• 22 Nowack W J, Hatelid J M, Sohn R S. Dysphagia in parkinsonism.  Arch Neurol. 1977;  34 320
• 23 Palmer E D. Dysphagia in parkinsonism.  JAMA. 1974;  229 1349
• 24 Calne D B, Shaw D G, Spiers A SD. et al . Swallowing in parkinsonism.  Br J Radiol. 1979;  43 456-457
• 25 Korczyn A D. Autonomic nervous system disturbances in Parkinson's disease.  Adv Neurol. 1990;  53 463-468
• 26 Kurlan R, Rubin A J, Miller C. et al . Continuous intraduodenal infusion of levodopa for resistant on-off fluctuations in parkinsonism.  Ann Neurol. 1985;  18 139
• 27 Champion M C. Domperidone.  Gen Pharmac. 1988;  19 499-505
• 28 Parkes J D. Domperidone and Parkinson's disease.  Clin Neuropharmacol. 1986;  9 517-532
• 29 Jost W H, Schimrigk K. Constipation in Parkinson's disease.  Klin Wochenschr. 1991;  69 906-909
• 30 Jost W H, Jung G, Schimrigk K. Colonic transit in non - idiopathic Parkinson's syndrome.  Eur Neurol. 1994;  34 329-331
• 31 Ashraf W, Wszolek Z K, Pfeiffer R F. et al . Anorectal function in fluctuating (on-off) Parkinson's disease: evaluation by combined anorectal manometry and electromyography.  Mov Disord. 1995;  10 650-657
• 32 Mathers S E, Kempster P A, Law P J. et al . Anal sphincter dysfunction in Parkinson's disease.  Arch Neurol. 1989;  46 1061-1064
• 33 Jost W H. Gastrointestinal motility problems in patients with Parkinson's disease: Effects of antiparkinsonian treatment and guidelines for management.  Drugs & Aging. 1997;  10 249-258
• 34 Lewy F H. Zur pathologischen Anatomie der Paralysis agitans.  Dtsch Z Nervenheilk. 1913;  50 50-55
• 35 Andersen J T, Hebjørn S, Frimodt-Møller C. et al . Disturbances of micturition in Parkinson's disease.  Acta Neurol Scand. 1976;  53 161-170
• 36 Raz S. Parkinsonism and neurogenic bladder.  Urol Res. 1976;  4 133-138
• 37 Galloway N TM. Urethral sphincter abnormalities in parkinsonism.  Br J Urol. 1983;  55 691-693
• 38 Singer C, Weiner W J, Sanchez-Ramos J R. et al . Sexual dysfunction in men with Parkinson's disease.  J Neuro Rehab. 1989;  3 199-204
• 39 Zesiewicz T A, Helal M, Hauser R A. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease.  Mov Disord. 2000;  15 305-308